1,396
Views
10
CrossRef citations to date
0
Altmetric
Research Article

Synthesis and neuroprotective effects of the complex nanoparticles of iron and sapogenin isolated from the defatted seeds of Camellia oleifera

, , &
Pages 428-434 | Received 05 Jul 2016, Accepted 30 Sep 2016, Published online: 09 Dec 2016

References

  • Bae EJ, Lee HJ, Rockenstein E, Ho DH, Park EB, Yang NY, Desplats P, Masliah E, Lee SJ. 2012. Antibody-aided clearance of extracellular α-synuclein prevents cell-to-cell aggregate transmission. J Neurosci. 32:13454–13469.
  • Balducci C, Forloni G. 2014. In vivo application of beta amyloid oligomers: a simple tool to evaluate mechanisms of action and new therapeutic approaches. Curr Pharm Des. 20:2491–2505.
  • Bellingham SA, Guo B, Hill AF. 2015. The secret life of extracellular vesicles in metal homeostasis and neurodegeneration. Biol Cell. 107:389–418.
  • Caboni P, Sherer TB, Zhan N, Taylor G, Na HM, Greenamyre JT, Casida JE. 2004. Rotenone, deguelin, their metabolites, and the rat model of Parkinson's disease. Chem Res Toxicol. 17:1540–1548.
  • Calabresi P, Centonze D, Gubellini P, Marfia GA, Pisani A, Sancesario G, Bernardi G. 2000. Synaptic transmission in the striatum: from plasticity to neurodegeneration. Prog Neurobiol. 61:231–265.
  • Colombelli C, Aoun M, Tiranti V. 2015. Defective lipid metabolism in neurodegeneration with brain iron accumulation (NBIA) syndromes: not only a matter of iron. J Inherit Metab Dis. 38:123–136.
  • Duty S. 2010. Therapeutic potential of targeting group III metabotropic glutamate receptors in the treatment of Parkinson's disease. Br J Pharmacol. 161:271–287.
  • Fernandez HH. 2015. 2015 Update on Parkinson disease. Cleve Clin J Med. 82:563–568.
  • Gao DF, Zhang YJ, Yang CR, Chen KK, Jiang HJ. 2008. Phenolic antioxidants from green tea produced from Camellia taliensis. J Agric Food Chem.56:7517–7521.
  • Gutowski M, Kowalczyk S. 2013. A study of free radical chemistry: their role and pathophysiological significance. Acta Biochim Polonica. 60:1–16.
  • Han YX, Wei XB, Xia LI, Ding Y, Xin H, Ding H. 2008. Protective effects of gypenosides against glutamate-induced hippocampus injury in rats. J Shandong Univ. 32:1683–1688.
  • He M, Zhao L, Wei MJ, Yao WF, Zhao HS, Chen FJ. 2009. Neuroprotective effects of (-)-epigallocatechin-3-gallate on aging mice induced by D-galactose. Biol Pharm Bull. 32:55–60.
  • Hersom M, Helms HC, Pretzer N, Goldeman C, Jensen AI, Severin G, Nielsen MS, Holm R, Brodin B. 2016. Transferrin receptor expression and role in transendothelial transport of transferrin in cultured brain endothelial monolayers. Mol Cell Neurosci. 76:59–67.
  • Jabir NR, Firoz CK, Baeesa SS, Ashraf GM, Akhtar S, Kamal W, Kamal MA, Tabrez S. 2014. Synopsis on the linkage of Alzheimer's and Parkinson's disease with chronic diseases. CNS Neurosci Ther. 21:1–7.
  • Kasote DM, Katyare SS, Hegde MV, Bae H. 2015. Significance of antioxidant potential of plants and its relevance to therapeutic applications. Int J Biol Sci. 11:982–991.
  • Kastner A, Hirsch EC, Agid Y, Javoy-Agid F. 1993. Tyrosine hydroxylase protein and messenger RNA in the dopaminergic nigral neurons of patients with Parkinson's disease. Brain Res. 606:341–345.
  • Kumar A, Singh A. Ekavali. 2015. A review on Alzheimer's disease pathophysiology and its management: an update. Pharmacol Rep. 67:195–203.
  • Labunskyy VM, Gladyshev VN. 2013. Role of reactive oxygen species-mediated signaling in aging. Antioxid Redox Signal. 19:1362–1372.
  • Lozoff B, Beard J, Connor J, Barbara F, Georgieff M, Schallert T. 2006. Long-lasting neural and behavioral effects of iron deficiency in infancy. Nutr Rev. 64:S34–S43.
  • Luo YM, Li B, Xie YH. 2003. Study on the chemical constituents of Camellia oleifera Abel. Chin Trad Herbal Drugs. 34:117–118.
  • Ma XY, Liu SB, Lu L, Li SF, Xie JJ, Zhang LY, Zhang JH, Luo XG. 2014. Relative bioavailability of iron proteinate for broilers fed a casein-dextrose diet. Poult Sci. 93:556–563.
  • Moreira CG, Barbiero JK, Ariza D, Dombrowski PA, Sabioni P, Bortolanza M, Da Cunha C, Vital MA, Lima MM. 2012. Behavioral, neurochemical and histological alterations promoted by bilateral intranigral rotenone administration: a new approach for an old neurotoxin. Neurotox Res. 21:291–301.
  • Murakami S, Miyazaki I, Sogawa N, Miyoshi K, Asanuma M. 2014. Neuroprotective effects of metallothionein against rotenone-induced myenteric neurodegeneration in Parkinsonian mice. Neurotox Res. 26:285–298.
  • Musa KH, Abdullah A, Kuswandi B, Hidayat MA. 2013. A novel high throughput method based on the DPPH dry reagent array for determination of antioxidant activity. Food Chem. 141:4102–4106.
  • Nday CM, Malollari G, Petanidis S, Salifoglou A. 2012. In vitro neurotoxic Fe(III) and Fe(III)-chelator activities in rat hippocampal cultures. From neurotoxicity to neuroprotection prospects. J Inorg Biochem. 117:342–350.
  • Ohno Y, Shimizu S, Tokudome K, Kunisawa N, Sasa M. 2015. New insight into the therapeutic role of the serotonergic system in Parkinson’s disease. Prog Neurobiol. 134:104–121.
  • Valerio LG. 2007. Mammalian iron metabolism. Toxicol Mech Methods. 17:497–517.
  • Venigalla M, Gyengesi E, Sharman MJ, Münch G. 2015. Novel promising therapeutics against chronic neuroinflammation and neurodegeneration in Alzheimer’s disease. Neurochem Inter. 10:1181–1185.
  • Venkateshappa C, Harish G, Mahadevan A, Srinivas Bharath MM, Shankar SK. 2012. Elevated oxidative stress and decreased antioxidant function in the human hippocampus and frontal cortex with increasing age: implications for neurodegeneration in Alzheimer’s disease. Neurochem Res. 37:1601–1614.
  • Wang P, Niu L, Guo XD, Li WX, Jia D, Wang XL, Ma LT, Gao GD. 2010. Gypenosides protect dopaminergic neurons in primary culture against MPP+-induced oxidative injury. Brain Res Bull. 83:266–271.
  • Wang Z, Zhang Q, Yuan L, Wang S, Liu L, Yang X, Li G, Liu D. 2014. The effects of curcumin on depressive-like behavior in mice after lipopolysaccharide administration. Behav Brain Res. 274:282–290.
  • Wei J, Chen XL, Sun H, Shen GX. 2012. Research progress on breeding and utilization of oil used Camellia L. Acta Agriculturae Zhejiangensis. 24:533–540.
  • Ye R, Yang Q, Kong X, Han J, Zhang X, Zhang Y, Li P, Liu J, Shi M, Xiong L, et al. 2011. Ginsenoside Rd attenuates early oxidative damage and sequential inflammatory response after transient focal ischemia in rats. Neurochem Inter. 58:391–398.
  • Ye Y, Chen X, Xing HT. 2013a. Hypolipidemic and antioxidant activities of hydrolyzed saponins from defatted seeds of Camellia oleifera Abel. Lat Am J Pharm. 32:409–417.
  • Ye Y, Fang F, Li Y. 2014. Isolation of the sapogenin from defatted seeds of Camellia oleifera and its neuroprotective effects on dopaminergic neurons. J Agric Food Chem. 62:6175–6182.
  • Ye Y, Xing HT, Chen X. 2013. Anti-inflammatory and analgesic activities of the hydrolyzed sasanquasaponins from the defatted seeds of Camellia oleifera. Arch Pharm Res. 36:941–951.
  • Zhao B. 2009. Natural antioxidants protect neurons in Alzheimer's disease and Parkinson's disease. Neurochem Res. 34:630–638.
  • Zhao YM, Li JQ, Lv FY, Yan Y, Xu QY. 2012. Activation of microglia and dopaminergic neurons degeneration following intraventricular injection of LPS in the substantia nigra of rats. Chin J Neuroimmunol Neurol. 19:121–145.
  • Zhou Q, Yin ZP, Ma L, Zhao W, Hao HW, Li HL. 2014. Free radical-scavenging activities of oligomeric proanthocyanidin from Rhodiola rosea L. and its antioxidant effects in vivo. Nat Prod Res. 28:2301–2303.